Showing posts with label Global Hemostats Market Trends. Show all posts
Showing posts with label Global Hemostats Market Trends. Show all posts
Leading players in the Global Hemostats Market projected to grow at a CAGR of  6.6% by 2024

Leading players in the Global Hemostats Market projected to grow at a CAGR of 6.6% by 2024

The market of global hemostats market is expected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Global Hemostats Market, By Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Application (Wound Closure, Surgery), Distribution Channel (Direct Tenders, Retail), End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa)


Market Segmentation:

The Global Hemostats Market is segmented on the basis of type, application, distribution channel, and end user. The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats.

On the basis of application, the Global Hemostats Market is segmented into surgery and wound closure.

On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics.


Drivers:

Some of the major factors driving the hemostats market are increasing number of minimally invasive surgeries, chronic conditions and aging population leading to increase in number of surgical procedures, expansion in healthcare infrastructure and expenditure, and technological advancements. These factors increase the demand for hemostats such as thrombin based haemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based hemostats and collagen based haemostats.

CHRONIC CONDITIONS AND AGING POPULATION LEADING TO INCREASE IN NUMBER OF SURGICAL PROCEDURES


TECHNOLOGICAL ADVANCEMENTS


INCREASING NUMBER OF MINIMALLY INVASIVE SURGERIES



Major Players:

Some of the major players operating in this market are Pfizer, C.R. Bard, Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited, Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt and Equimedical, B.V. among other companies.

Related Report

Global Medical Instruments Disinfections Market – Trends and Forecast to 2024

Global Medical Instruments Disinfection Market, By Product Type (Disinfectants (Wipes, Sprays, Liquid), Disinfectors, Endoscopic Reprocessors), End-Users, By Distribution Channel, By Geography (North America, Europe, Asia-Pacific, South America and Middle East and Africa) – Trends and Forecast to 2024


About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818

Hemostats Market 2017 Global Analysis by key Players – Pfizer, C.R. Bard, Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd. Forecast to 2024

Hemostats Market 2017 Global Analysis by key Players – Pfizer, C.R. Bard, Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd. Forecast to 2024

Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024

The global hemostats market has accounted to USD 2.7 billion in 2016, and is expected to reach USD 4.5 billion by 2024, growing at a CAGR of 6.5% in the forecast period 2017 to 2024.


Global Hemostats Market - Segmentation:

The global hemostats market is segmented based on product type, indication, end-user and geography.

On the basis of product the market is segmented into into 5 product type’s thrombin based hemostats, combination agents hemostats, oxidized regeneration cellulose based hemostats, gelatin based hemostats and collagen based segments.

The Global Hemostats Market is also segmented based on indications type into wound closure and surgery

Based on end-users the market is segmented into hospitals, clinics, ambulatory centers, community healthcare and others.


Global Hemostats Market - Geographical Segmentation

Based on geography the global hemostats devices market covers data points for 52 countries across multiple geographies namely North & South America, Europe, Asia-Pacific and, Middle East & Africa. North America dominates the market in terms of consumption of hemostats followed by Europe and APAC. . In terms of revenue North America holds 57.7% of the market in 2015, followed by Europe with 20.1% and APAC with 14.2%. APAC is expected to be the fastest growing market in the forecasted years owing to increasing number of surgeries in this region among other growth opportunities.

Global Hemostats Market - Competitive Landscape:

The Global Hemostats market is highly competitive and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some of the recent developments in the hemostats market are: April 2015, Ethicon’s fibrin sealant patch received food and drug administration approval for extended surgical indications; April 2016, 3-D Matrix Europe subsidiary entered partnership with Chile based M. Kaplan Y CIA LTDA. for sistribution rights of PuraStat hemostat of 3-D Matrix in Chile. The report includes market shares of global hemostats market for U.S., Canada, Brazil, Mexico, Germany, France, U.K., China, India, Japan, North America, South America, Europe, Asia-Pacific and Middle East and Africa.

Some of the major players operating in this market are Pfizer, C.R. Bard, Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (A Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, Medtrade Products Ltd., Integra Lifesciences Corporation, Medline Industries, Inc., Hemotec Medical GmbH, Stryker, Hemostasis, LLC., CSL Behring, Mallinckrodt plc. and Equimedical, B.V. among other companies.


Table of Content:

1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. HEMOSTATS MARKET, BY PRODUCT TYPE
6. HEMOSTATS MARKET,  BY INDICATION
7. HEMOSTATS MARKET,  BY END-USER
8. HEMOSTATS MARKET, BY GEOGRAPHY
      8.1. COUNTRYWISE HEMOSTATS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
      8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
9. HEMOSTATS MARKET: COMPETITIVE LANDSCAPE
      9.1. GLOBAL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
      9.2. U.S. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
      9.3. EUROPE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
      9.4. ASIA-PACIFIC HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
      9.5. MERGERS & ACQUISITIONS
      9.6. NEW PRODUCT DEVELOPMENT & APPROVALS
      9.7. EXPANSIONS
      9.8. REGULATORY CHANGES
      9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10. HEMOSTATS MARKET, COMPANY PROFILES
      10.1. ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)
      10.2. PFIZER
      10.3. C.R. BARD
      10.4. BAXTER
      10.5. VASCULAR SOLUTIONS, INC.
      10.6. B.BRAUN MELSUNGEN
      10.7. 3-D MATRIX, LTD
      10.8. RESORBA MEDICAL GMBH (A ADVANCED MEDICAL SOLUTIONS GROUP PLC COMPANY)
      10.9. ANIKA THERAPEUTICS, INC.
      10.10. ARCH THERAPEUTICS INC.
      10.11. BIOM’UP SAS
      10.12. CRYOLIFE, INC.
      10.13. GAMMA THERAPEUTICS, INC.
      10.14. HEMOSTASIS, LLC
      10.15. MEDTRADE PRODUCTS LTD.
      10.16. INTEGRA LIFESCIENCES CORPORATION
      10.17. MEDLINE INDUSTRIES, INC.
      10.18. HEMOTEC MEDICAL GMBH
               10.18.1. OVERVIEW
               10.18.2. SWOT ANALYSIS
               10.18.3. PRODUCT PORTFOLIO
               10.18.4. REVENUE ANALYSIS
               10.18.5. ANALYSTS VIEW
      10.19. STRYKER
                10.19.1. OVERVIEW
                10.19.2. SWOT ANALYSIS
                10.19.3. PRODUCT PORTFOLIO
                10.19.4. REVENUE ANALYSIS
               10.19.5. ANALYSTS VIEW
      10.20. HEMOSTASIS, LLC.
               10.20.1. OVERVIEW
               10.20.2. SWOT ANALYSIS
                10.20.3. PRODUCT PORTFOLIO
                10.20.4. REVENUE ANALYSIS
                10.20.5. ANALYSTS VIEW
      10.21. CSL BEHRING
               10.21.1. OVERVIEW
               10.21.2. SWOT ANALYSIS
               10.21.3. PRODUCT PORTFOLIO
               10.21.4. REVENUE ANALYSIS
               10.21.5. ANALYSTS VIEW
      10.22. MALLINCKRODT PLC.
               10.22.1. OVERVIEW
               10.22.2. SWOT ANALYSIS
               10.22.3. PRODUCT PORTFOLIO
               10.22.4. REVENUE ANALYSIS
               10.22.5. ANALYSTS VIEW
      10.23. EQUIMEDICAL, B.V.
               10.23.1. OVERVIEW
               10.23.2. SWOT ANALYSIS
               10.23.3. PRODUCT PORTFOLIO
               10.23.4. REVENUE ANALYSIS
               10.23.5. ANALYSTS VIEW

Related Report

Global Medical Instruments Disinfections Market – Trends and Forecast to 2024

Global Medical Instruments Disinfection Market, By Product Type (Disinfectants (Wipes, Sprays, Liquid), Disinfectors, Endoscopic Reprocessors), End-Users, By Distribution Channel, By Geography (North America, Europe, Asia-Pacific, South America and Middle East and Africa) – Trends and Forecast to 2024


About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Hemostats Market - Global Trends and Forecast to 2024 | Data Bridge Market Research

Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024

The global hemostats market has accounted to USD 2.7 billion in 2016, and is expected to reach USD 4.5 billion by 2024, growing at a CAGR of 6.5% in the forecast period 2017 to 2024.


The global hemostats market is segmented into based on product type, indication, end-user and geography.

On the basis of product types the global hemostats market is segmented into 5 product type’s thrombin based hemostats, combination agents hemostats, oxidized regeneration cellulose based hemostats, gelatin based hemostats and collagen based segments. The market report covers market value and volume of the segments mentioned earlier. In 2015, in terms of market value the thrombin based hemostats market segment dominates the market with 34.1% market share. While the combination based hemostats market is expected to grow at the highest CAGR in the forecast period of 2016 to 2022. In terms of volume the hemostats market is dominated by thrombin based hemostats with 41.7% market share in 2015.

The global hemostats market is further segmented based on indications into wound closure and surgery. The surgery segment dominates the market in 2015.

The global hemostats market is further segmented on the basis of end users into hospitals, clinics, ambulatory centers, community healthcare and others.


The global hemostats market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. Some of the recent developments in the hemostats market are: April 2015, Ethicon’s fibrin sealant patch received food and drug administration approval for extended surgical indications; April 2016, 3-D Matrix Europe subsidiary entered partnership with Chile based M. Kaplan Y CIA LTDA. for sistribution rights of PuraStat hemostat of 3-D Matrix in Chile. The global hemostats market report also contains market share by manufacturer’s data for U.S., Canada, Brazil, Mexico, Germany, France, U.K., China, India, Japan, North America, South America, Europe, Asia-Pacific and Middle East and Africa.

Based on geography the Global Hemostats Market is segmented into:

·         North America
·         South America
·         Europe
·         Asia-Pacific
·         Middle East and Africa


Some of the major companies operating in this market are:

·         Pfizer
·         C.R. Bard
·         Baxter
·         Vascular Solutions, Inc.
·          B.Braun Melsungen
·         3-D Matrix, Ltd.
·         Resorba Medical GmbH (A Advanced Medical Solutions Group plc Company)
·         Anika Therapeutics, Inc.
·         Arch Therapeutics Inc.
·         Biom’Up SAS
·         CryoLife, Inc.
·         Gamma Therapeutics, Inc.
·         Hemostasis, LLC
·          Medtrade Products Ltd.
·         Integra Lifesciences Corporation
·         Medline Industries, Inc.
·         Hemotec Medical GmbH
·         Stryker
·         Hemostasis
·         LLC.
·         CSL Behring
·         Mallinckrodt plc.
·         Equimedical, B.V.

Table of Content:

1. INTRODUCTION
      1.1. OVERVIEW OF THE  HEMOSTATS MARKET
      1.2. MARKET SEGMENTATION & COVERAGE
2. RESEARCH METHODOLOGY
      2.1. KEY TAKEAWAYS
      2.2. ARRIVING AT THE GLOBAL HEMOSTATS MARKET
      2.3. GLOBAL HEMOSTATS MARKET: RESEARCH SNAPSHOT
      2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
      4.1. OVERVIEW
      4.2. GLOBAL HEMOSTATS MARKET: KEY PRIMARY INSIGHTS
      4.3. MARKET OVERVIEW
      4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. HEMOSTATS MARKET, BY PRODUCT TYPE
6. HEMOSTATS MARKET,  BY INDICATION
7. HEMOSTATS MARKET,  BY END-USER
8. HEMOSTATS MARKET, BY GEOGRAPHY
      8.1. COUNTRYWISE HEMOSTATS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
               8.1.1. NORTH AMERICA
               8.1.2. EUROPE
               8.1.3. ASIA-PACIFIC (APAC)         
               8.1.4. LATIN AMERICA
               8.1.5. MIDDLE EAST AND AFRICA
      8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
9. HEMOSTATS MARKET: COMPETITIVE LANDSCAPE
      9.1. GLOBAL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
      9.2. U.S. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
      9.3. EUROPE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
      9.4. ASIA-PACIFIC HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
      9.5. MERGERS & ACQUISITIONS
      9.6. NEW PRODUCT DEVELOPMENT & APPROVALS
      9.7. EXPANSIONS
      9.8. REGULATORY CHANGES
      9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10. HEMOSTATS MARKET, COMPANY PROFILES
      10.1. ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)
      10.2. PFIZER
      10.3. C.R. BARD
      10.4. BAXTER
      10.5. VASCULAR SOLUTIONS, INC.
      10.6. B.BRAUN MELSUNGEN
      10.7. 3-D MATRIX, LTD
      10.8. RESORBA MEDICAL GMBH (A ADVANCED MEDICAL SOLUTIONS GROUP PLC COMPANY)
      10.9. ANIKA THERAPEUTICS, INC.
      10.10. ARCH THERAPEUTICS INC.
      10.11. BIOM’UP SAS
      10.12. CRYOLIFE, INC.
      10.13. GAMMA THERAPEUTICS, INC.
      10.14. HEMOSTASIS, LLC
      10.15. MEDTRADE PRODUCTS LTD.
      10.16. INTEGRA LIFESCIENCES CORPORATION
      10.17. MEDLINE INDUSTRIES, INC.
      10.18. HEMOTEC MEDICAL GMBH
               10.18.1. OVERVIEW
               10.18.2. SWOT ANALYSIS
               10.18.3. PRODUCT PORTFOLIO
               10.18.4. REVENUE ANALYSIS
               10.18.5. ANALYSTS VIEW
      10.19. STRYKER
                10.19.1. OVERVIEW
                10.19.2. SWOT ANALYSIS
                10.19.3. PRODUCT PORTFOLIO
                10.19.4. REVENUE ANALYSIS
               10.19.5. ANALYSTS VIEW
      10.20. HEMOSTASIS, LLC.
               10.20.1. OVERVIEW
               10.20.2. SWOT ANALYSIS
                10.20.3. PRODUCT PORTFOLIO
                10.20.4. REVENUE ANALYSIS
                10.20.5. ANALYSTS VIEW
      10.21. CSL BEHRING
               10.21.1. OVERVIEW
               10.21.2. SWOT ANALYSIS
               10.21.3. PRODUCT PORTFOLIO
               10.21.4. REVENUE ANALYSIS
               10.21.5. ANALYSTS VIEW
      10.22. MALLINCKRODT PLC.
               10.22.1. OVERVIEW
               10.22.2. SWOT ANALYSIS
               10.22.3. PRODUCT PORTFOLIO
               10.22.4. REVENUE ANALYSIS
               10.22.5. ANALYSTS VIEW
      10.23. EQUIMEDICAL, B.V.
               10.23.1. OVERVIEW
               10.23.2. SWOT ANALYSIS
               10.23.3. PRODUCT PORTFOLIO
               10.23.4. REVENUE ANALYSIS
               10.23.5. ANALYSTS VIEW

Related Report

Global Medical Instruments Disinfections Market – Trends and Forecast to 2024

Global Medical Instruments Disinfection Market, By Product Type (Disinfectants (Wipes, Sprays, Liquid), Disinfectors, Endoscopic Reprocessors), End-Users, By Distribution Channel, By Geography (North America, Europe, Asia-Pacific, South America and Middle East and Africa) – Trends and Forecast to 2024


About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
Powered by Blogger.